For research use only. Not for therapeutic Use.
Hydroxy Dabrafenib (CAT: C000221) is a derivative of Dabrafenib, a medication used in the treatment of certain types of cancer, particularly melanoma with specific genetic mutations. Hydroxy Dabrafenib may be a metabolite or an intermediate in the metabolism or synthesis of Dabrafenib.
| Catalog Number | C000221 |
| CAS Number | 1195767-77-1 |
| Synonyms | N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(2-hydroxy-1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide |
| Molecular Formula | C₂₃H₂₀F₃N₅O₃S₂ |
| Purity | ≥95% |
| Solubility | DMSO (Slightly), Methanol (Slightly) |
| Appearance | White to Off-White Solid |
| Storage | 4°C, Inert atmosphere |
| Reference | Vikingsson, S., et al.: Analy. and Bioanaly. Chem., 409(15), 3749-3756 (2017); Bershas, D. A., et al.: Drug Metabol. & Dispos., 41(12), 2215-2224 (2013) |
